Get started
Author

Marc Delforge

Observed names: Delforge, Marc, M Delforge, M L Delforge, M. Delforge, M.L. Delforge
ORCID: 0000-0001-9002-0598
Observed ORCID: 0000-0001-9002-0598
OpenAlex ID: A5007869839
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
2019 · Deepak L Bhatt, Philippe Gabriel Steg, et al. · The Lancet · 214
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff
2020 · C. Martin, I. Montesinos, et al. · Journal of Hospital Infection · 104
PDF
Sustained Viral Suppression and Higher CD4+ T-Cell Count Reduces the Risk of Persistent Cervical High-Risk Human Papillomavirus Infection in HIV-Positive Women
2013 · D. Konopnicki, Y. Manigart, et al. · The Journal of Infectious Diseases · 87
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons
2013 · Margalida Rotger, Tracy R. Glass, et al. · Clinical Infectious Diseases · 77
PDF
Characteristics of non‐AIDS‐defining malignancies in the HAART era: a clinico‐epidemiological study
2011 · Nicolas Dauby, Stéphane De Wit, et al. · Journal of the International AIDS Society · 57
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
2019 · Shinya Goto, Pantep Angchaisuksiri, et al. · Journal of the American Heart Association · 56
Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005–2019
2020 · Elena Graux, Maya Hites, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 53
PDF
Evaluation of the new LIAISON ® CMV IgG, IgM and IgG Avidity II assays
2015 · M.L. Delforge, L. Desomberg, et al. · Journal of Clinical Virology · 52
Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005–2020
2023 · Lisa Zangarini, Delphine Martiny, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 39
PDF
Down regulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load
2011 · Stéphane De Wit, Marc Delforge, et al. · AIDS · 32
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium
2023 · Rakan Nasreddine, Eric Florence, et al. · HIV Medicine · 29
PDF
High‐risk human papillomavirus infection in HIV‐positive African women living in Europe
2013 · Deborah Konopnicki, Yannick Manigart, et al. · Journal of the International AIDS Society · 29
PDF
Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study
2016 · Agnès Libois, Francesco Feoli, et al. · Sexually Transmitted Infections · 26
Homeless people hospitalized with COVID-19 in Brussels
2020 · Loïc Schrooyen, Marc Delforge, et al. · Clinical Microbiology and Infection · 23
PDF
Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study
2018 · Agnès Libois, Marie Hallin, et al. · PLoS ONE · 22
PDF
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
2018 · Jitendra PS. Sawhney, Veerappa A. Kothiwale, et al. · Indian Heart Journal · 21
PDF
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium
2022 · Rakan Nasreddine, Jean Cyr Yombi, et al. · HIV Medicine · 20
PDF
Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients
2020 · Rakan Nasreddine, Eric Florence, et al. · AIDS · 20
PDF
Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study
2019 · Elizabeth Chappell, Andrew Riordan, et al. · Clinical Infectious Diseases · 19
PDF
Hyponatremia is a marker of disease severity in HIV-infected patients: a retrospective cohort study
2017 · Philippe Braconnier, Marc Delforge, et al. · BMC Infectious Diseases · 18
PDF
High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus
2015 · Deborah Konopnicki, Yannick Manigart, et al. · AIDS · 16
Cardiovascular risk evaluation of HIV‐positive patients in a case‐control study: comparison of the D:A:D and Framingham equations
2014 · Samuel Markowicz, Marc Delforge, et al. · Journal of the International AIDS Society · 16
PDF
Treatment of anal dysplasia in HIV-positive men who have sex with men in a large AIDS reference centre
2016 · Nathalie Willems, Agnès Libois, et al. · Acta Clinica Belgica · 15
HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors
2015 · Marcel Nkuize, Stéphane De Wit, et al. · PLoS ONE · 15
PDF
First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting
2014 · Nathan Clumeck, Claude Mwamba, et al. · AIDS · 15
Works count: 96
Citation count: 1,254
H-index: 19
I10-index: 29
Year
Topic
Type